Medical Economics March 3, 2023
Richard Payerchin

MGMA agrees accurate billing is essential, but more information is needed before changing the system next year.

More time and explanation would help physicians and administrators understand changes that could be coming for Medicare Advantage (MA) plans next year.

The U.S. Centers for Medicare & Medicaid Services (CMS) has published its 2024 Advance Notice for the Medicare Advantage and Part D Prescription Drug Programs for updates that would take effect Jan. 1, 2024.

The Medical Group Management Association (MGMA) has asked for more time and for additional details from CMS to determine how proposed changes will affect its members, which range from small, rural practices, to large regional and national health systems.

At least one issue is a...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: CMS, Govt Agencies, HIM (Health Inf Mgmt), Insurance, Medicare, Physician, Provider, Technology
Related Articles:
‘An exciting time for osteopathic medicine’ — growth in numbers, influence, financial effect
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Osteopathic medical education: ‘This is an exciting time’
283: A candid conversation: Physicians on the front lines of GLP‑1 care
Inside physician engagement: When uncertainty rises, engagement matters more

Share Article